Calcium Channel Blocker Class Heterogeneity: Select Aspects of Pharmacokinetics and Pharmacodynamics
Open Access
- 1 April 2005
- journal article
- research article
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 7 (s4) , 21-26
Abstract
Calcium channel blockers (CCBs) comprise a heterogeneous group of compounds with unique structures and pharmacologic characteristics. These agents are employed in the treatment of hypertension, coronary ischemia, and/or supraventricular arrhythmias. CCBs are both substrates for, and in the instance of verapamil and diltiazem inhibitors of, cytochrome P450 3A4. In the case of verapamil and diltiazem, this inhibitory effect increases the likelihood of drug‐drug interactions with other compounds similarly metabolized by cytochrome P450 3A4. Much of the debate with reference to a cardiovascular risk for CCBs has been quieted with the advent of sustained‐release delivery systems that offer a more gradual rate of drug delivery. The most common side effects with CCBs are vasodilatory in nature and include peripheral edema, flushing, and headache. Despite the potential for side effects with CCBs, their potent blood pressure‐lowering effect makes them a prerequisite for blood pressure control in many patients.Keywords
This publication has 25 references indexed in Scilit:
- Calcium-channel blockers and end-stage renal disease: pharmacokinetic and pharmacodynamic considerationsCurrent Opinion in Nephrology and Hypertension, 2003
- Drug Delivery Systems for Treatment of Systemic HypertensionClinical Pharmacokinetics, 2003
- Rhabdomyolysis and Satin Therapy: Relevance to the ElderlyThe American Journal of Geriatric Cardiology, 2002
- Calcium-Antagonist DrugsNew England Journal of Medicine, 1999
- The Use of Other Drugs to Allow a Lower Dosage of Cyclosporin to Be UsedClinical Pharmacokinetics, 1997
- Calcium Antagonists in the ElderlyDrugs & Aging, 1996
- Safety and efficacy of intravenousdiltiazem in atrial fibrillation or atrial flutterThe American Journal of Cardiology, 1995
- The Effect of Nifedipine on the Pharmacokinetics and Dynamics of Diltiazem: The Preliminary Study in Normal VolunteersThe Journal of Clinical Pharmacology, 1993
- Effects of Diltiazem on the Pharmacokinetics of NifedipinJournal of Cardiovascular Pharmacology, 1990
- Dose Dependent Effect of Diltiazem on the Pharmacokinetics of NifedipineThe Journal of Clinical Pharmacology, 1989